• miDiagnostics raises €14m to accelerate the commercialization of its disruptive, lab-quality silicon chip diagnostics platform

    Thursday March 26th 2020

  • University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    Wednesday March 25th 2020

  • iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

    Wednesday February 26th 2020

  • Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

    Monday January 13th 2020

  • Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis

    Monday January 13th 2020

  • Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF)

    Wednesday January 8th 2020

  • Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME

    Tuesday January 7th 2020

  • Your news here?


Strategic Partners